FORM 3
        	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
	OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

Balousek Jon M	2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2013 
	3. Issuer Name and Ticker or Trading Symbol

CLOROX CO /DE/ [CLX]	
(Last)        (First)        (Middle)

1221 BROADWAY	4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP - GM, Specialty Div /	
(Street)

OAKLAND, CA 94612-1888       

(City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY)

	6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Beneficially Owned	
1.Title of Security
(Instr. 4)	2. Amount of Securities Beneficially Owned
(Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)	4. Nature of Indirect Beneficial Ownership
(Instr. 5)	
Common Stock  	5911.0000  	D  	 	

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 4)	2. Date Exercisable and Expiration Date
(MM/DD/YYYY)	3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)	6. Nature of Indirect Beneficial Ownership
(Instr. 5)	
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares				
Stock Option (Right to Buy)  	9/21/2006   (1)	9/21/2015  	Common Stock  	3610.0000  	$57.0000  	D  	 	
Stock Option (Right to Buy)  	9/15/2010   (1)	9/15/2019  	Common Stock  	8240.0000  	$57.2500  	D  	 	
Stock Option (Right to Buy)  	9/18/2008   (1)	9/18/2017  	Common Stock  	5570.0000  	$61.1600  	D  	 	
Stock Option (Right to Buy)  	9/19/2007   (1)	9/19/2016  	Common Stock  	3680.0000  	$61.5100  	D  	 	
Stock Option (Right to Buy)  	9/16/2009   (1)	9/16/2018  	Common Stock  	6500.0000  	$63.9500  	D  	 	
Stock Option (Right to Buy)  	9/14/2011   (1)	9/14/2020  	Common Stock  	13940.0000  	$66.4800  	D  	 	
Stock Option (Right to Buy)  	9/13/2012   (1)	9/13/2021  	Common Stock  	16200.0000  	$68.1500  	D  	 	
Stock Option (Right to Buy)  	9/11/2013   (1)	9/11/2022  	Common Stock  	21550.0000  	$72.1100  	D  	 	

Explanation of Responses:	
(  1) 	Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
Balousek Jon M
1221 BROADWAY
OAKLAND, CA 94612-1888			SVP - GM, Specialty Div		

Signatures		
By Cheryl Brice, Attorney-in-Fact for		1/4/2013	
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.